125 related articles for article (PubMed ID: 38035445)
21. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
22. Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Yang Z; Huang J; Wu X; Zhou Y; Tang Y; Zhu Y; Li B; Chen X; Yao W
J Cancer; 2024; 15(6):1583-1592. PubMed ID: 38370369
[No Abstract] [Full Text] [Related]
23. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA.
Wu H; Guo S; Liu X; Li Y; Su Z; He Q; Liu X; Zhang Z; Yu L; Shi X; Gao S; Wang H; Pan Y; Ma C; Liu R; Dai M; Jin G; Liang Z
BMC Med; 2022 Nov; 20(1):458. PubMed ID: 36434648
[TBL] [Abstract][Full Text] [Related]
25. An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
Makler A; Narayanan R; Asghar W
Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36290970
[TBL] [Abstract][Full Text] [Related]
26. Involvement of anti-tumor
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
[TBL] [Abstract][Full Text] [Related]
27. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
29. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
Cote GA; Gore AJ; McElyea SD; Heathers LE; Xu H; Sherman S; Korc M
Am J Gastroenterol; 2014 Dec; 109(12):1942-52. PubMed ID: 25350767
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis.
Lemberger M; Loewenstein S; Lubezky N; Nizri E; Pasmanik-Chor M; Barazovsky E; Klausner JM; Lahat G
Oncotarget; 2019 Apr; 10(27):2644-2656. PubMed ID: 31080555
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
[TBL] [Abstract][Full Text] [Related]
32. miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer.
Zhang C; Yang J; Chen Y; Jiang F; Liao H; Liu X; Wang Y; Kong G; Zhang X; Li J; Gao J; Shen L
Gastric Cancer; 2022 Mar; 25(2):360-374. PubMed ID: 35031872
[TBL] [Abstract][Full Text] [Related]
33. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection.
Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582
[TBL] [Abstract][Full Text] [Related]
34. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
Kandimalla R; Shimura T; Mallik S; Sonohara F; Tsai S; Evans DB; Kim SC; Baba H; Kodera Y; Von Hoff D; Chen X; Goel A
Ann Surg; 2022 Jan; 275(1):e229-e237. PubMed ID: 32398486
[TBL] [Abstract][Full Text] [Related]
35. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
[TBL] [Abstract][Full Text] [Related]
36. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
37. Overexpression Of hsa-miR-664a-3p Is Associated With Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Via Targeting FHL1.
Zhong S; Chen C; Liu N; Yang L; Hu Z; Duan P; Shuai D; Zhang Q; Wang Y
Int J Chron Obstruct Pulmon Dis; 2019; 14():2319-2329. PubMed ID: 31632001
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression
Wang HQ; Qian CH; Guo ZY; Li PM; Qiu ZJ
World J Gastroenterol; 2022 Sep; 28(35):5141-5153. PubMed ID: 36188725
[TBL] [Abstract][Full Text] [Related]
39. LINC00483 promotes proliferation and metastasis through the miR-19a-3p/TBK1/MAPK axis in pancreatic ductal adenocarcinoma (PDAC).
Ni C; Zheng K; Liu W; Ou Y; Li G; Jin G
Ann Transl Med; 2022 Mar; 10(6):317. PubMed ID: 35433983
[TBL] [Abstract][Full Text] [Related]
40. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
